Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Return on Sales (2022 - 2025)

Cannabis Bioscience International Holdings' Return on Sales history spans 3 years, with the latest figure at 2.14% for Q4 2025.

  • For Q4 2025, Return on Sales fell 118.0% year-over-year to 2.14%; the TTM value through Nov 2025 reached 3.58%, down 213.0%, while the annual FY2025 figure was 1.39%, 118.0% up from the prior year.
  • Return on Sales for Q4 2025 was 2.14% at Cannabis Bioscience International Holdings, up from 3.81% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.56% in Q3 2024 and bottomed at 9.99% in Q1 2025.
  • The 3-year median for Return on Sales is 2.7% (2023), against an average of 3.71%.
  • The largest annual shift saw Return on Sales soared 430bps in 2024 before it crashed -347bps in 2025.
  • A 3-year view of Return on Sales shows it stood at 1.95% in 2023, then skyrocketed by 51bps to 0.95% in 2024, then tumbled by -124bps to 2.14% in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Return on Sales are 2.14% (Q4 2025), 3.81% (Q3 2025), and 2.9% (Q2 2025).